Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Change in Cash (2021 - 2026)

HeartSciences (HSCS) has disclosed Change in Cash for 5 consecutive years, with -$841128.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash fell 192.41% year-over-year to -$841128.0, compared with a TTM value of -$2.1 million through Oct 2025, down 153.16%, and an annual FY2025 reading of -$4.7 million, down 213.56% over the prior year.
  • Change in Cash was -$841128.0 for Q4 2025 at HeartSciences, down from $1.7 million in the prior quarter.
  • Across five years, Change in Cash topped out at $7.0 million in Q1 2024 and bottomed at -$1.5 million in Q2 2025.
  • Average Change in Cash over 5 years is $68201.2, with a median of -$596500.5 recorded in 2021.
  • The sharpest move saw Change in Cash crashed 428.37% in 2022, then skyrocketed 709.28% in 2024.
  • Year by year, Change in Cash stood at $364389.0 in 2021, then plummeted by 428.37% to -$1.2 million in 2022, then surged by 60.26% to -$475510.0 in 2023, then soared by 39.51% to -$287658.0 in 2024, then crashed by 192.41% to -$841128.0 in 2025.
  • Business Quant data shows Change in Cash for HSCS at -$841128.0 in Q4 2025, $1.7 million in Q3 2025, and -$1.5 million in Q2 2025.